FIT vs gFOBTs: What’s changed? 

Friday 18th October 2019

The new Faecal Immunochemical Test (FIT) rolled out across England this year has a number of benefits in replacing the use of older guaiac-based faecal occult blood tests (gFOBTs). Is your practice up to date with the new processes associated with FIT and are you aware of the reasons for the change?

Our latest course on Faecal Immunochemical Testing (FIT) is now available, outlining the use of FIT as a screening tool and appropriate use for symptomatic patients. It also includes some of the key benefits of changing to this method from gFOBTs, including:

  • Increased reliability as an indicator of abnormal pathology
  • The need for one patient sample only, compared to the previous three
  • Using antibodies that specifically recognise human haemoglobin
  • Reducing the number of repeat tests, as there are no borderline results (only normal or abnormal)

Find out more:

Find out more: visit the GatewayC Faecal Immunochemical Test course here. 1 CPD credit is available upon completion of this course.

Keep up to date: Twitter | Facebook | LinkedIn

Latest from the Blog

Cancer Keys: Oesophageal cancer and dysphagia

Cancer Keys: Oesophageal cancer and dysphagia

Potential pitfall: Dysphagia is the most common presenting symptom of oesophageal cancer. It should be considered alongside a number of other symptoms when contemplating an upper gastrointestinal cancer referral. Helpful hint: NICE NG12 guidelines recommend offering...

read more
4 Tips to Manage Barrett’s Oesophagus

4 Tips to Manage Barrett’s Oesophagus

Thursday 4th March 2021 Barrett's oesophagus is associated with an increased risk of oesophageal cancer. When supporting a patient with Barrett’s oesophagus, are you clear on how to manage the condition? 4 tips to manage Barrett’s oesophagus in primary care include:...

read more

Related Posts

NEW COURSE: Oesophageal Cancer – Early Diagnosis

NEW COURSE: Oesophageal Cancer – Early Diagnosis

Thursday 25th February 2021 We are delighted to announce that the new Oesophageal Cancer - Early Diagnosis course is now available on GatewayC. Oesophageal cancer is the 14th most common cancer in the UK, accounting for 3% of all new cancer cases with the highest...

read more
Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more